Journal article
Immunomodulation and Reduction of Thromboembolic Risk in Hospitalized COVID-19 Patients: Systematic Review and Meta-Analysis of Randomized Trials
Abstract
BACKGROUND: We aimed to investigate the potential beneficial effect of immunomodulation therapy on the thromboembolic risk in hospitalized COVID-19 patients.
METHODS: We searched PubMed and Scopus for randomized trials reporting the outcomes of venous thromboembolism (VTE), ischemic stroke or systemic embolism, myocardial infarction, any thromboembolic event, and all-cause mortality in COVID-19 patients treated with immunomodulatory agents. …
Authors
Sagris D; Florentin M; Tasoudis P; Korompoki E; Gatselis N; Giamarellos-Bourboulis EJ; Milionis H; Douketis J; Spyropoulos AC; Dalekos G
Journal
Journal of Clinical Medicine, Vol. 10, No. 22,
Publisher
MDPI
DOI
10.3390/jcm10225366
ISSN
2077-0383